GENinCode Plc (AIM:GENI)
London
· Delayed Price · Currency is GBP · Price in GBX 2.050
-0.100 (-4.65%)
Jun 13, 2025, 9:08 AM GMT+1
GENinCode Revenue
In the year 2024, GENinCode had annual revenue of 2.70M GBP with 25.05% growth. GENinCode had revenue of 1.31M in the half year ending December 31, 2024, with 71.28% growth.
Revenue
2.70M
Revenue Growth
+25.05%
P/S Ratio
2.28
Revenue / Employee
64.31K
Employees
42
Market Cap
6.17M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
GENinCode News
- 4 months ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 5 months ago - AIM Market Roundup: GENinCode, Empyrean, Watkins Jones - The Armchair Trader
- 9 months ago - Half Year 2024 Genincode PLC Earnings Presentation Transcript - GuruFocus
- 9 months ago - Half Year 2024 Genincode PLC Earnings Presentation (Shareholder Q&A) Transcript - GuruFocus